2020-11-01
Czech Liaison Office for Research, Development and Innovation (CZELO) distinguished our project as the example of good practice realized with the support from Horizon 2020 by the company from Visegrad countries (see page 58 of the brochure)
Link
https://cordis.europa.eu/project/id/830559
Download PDF
https://poltreg.com/wp-content/uploads/2020/12/CZELO-V4-Brochure-H2020-Good-Practice.pdf
2025-08-04
PolTREG Doses First Patient in Phase II Trial for Pre-Symptomatic Type 1 Diabetes with PTG-007
2025-07-31
PolTREG Secures Positive FDA Opinion, Paving the Way for a Registrational Pre-Symptomatic Type 1 Diabetes Trial
2025-06-13
PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy
